RHI Magnesita have introduced the “4PRO” – a new refractory solutions contract model. The model is designed to lead ...

RHI Magnesita, the global leader in refractory products and solutions, proudly introduces “4PRO” – a new refractory solutions contract model. The transformative business model is designed to lead high ...

HarbisonWalker International is investing $13.9 million in Fulton, creating 11 new jobs with a modern facility expanding ...

A company's $13.9 million expansion in Fulton will create 11 new jobs and a state-of-the-art manufacturing facility.

Illumina, a United States-headquartered company specializing in DNA sequencing and array-based technologies, is showcasing ...

Checkpoint Inhibitor Refractory Cancer Market Uncover key developments in the checkpoint inhibitor refractory cancer market, focusing on ...

Aucatzyl is the first CAR-T cell therapy approved by the FDA with no requirement for a risk evaluation mitigation strategy ...

Multiple myeloma is the second most common hematologic malignancy, but there is a treatment gap for patients with disease ...

AI productivity software, along with AI PCs, are the products that are bringing AI capabilities to the masses. Businesses and organizations are rapidly expanding their use of AI. Building ...

The FDA has granted LBL-034 orphan drug designation for relapsed/refractory multiple myeloma treatment. LBL-034 has received ...